Key Takeaway: The Epilepsy Foundation aims to end epilepsy by raising awareness and improving lives through various initiatives. Their efforts include advocacy, research, education, and mobilizing community action. The foundation is dedicated to changing the conversation around epilepsy and promoting new therapies.
Price reaction · baseline $3.525 (2023-09-22T16:34:00.000Z) · hit during market hours · 18 other OVID headline(s) in the window, move may be shared
day 0 close · peak
+3.3%
Market Sentiment Analysis
POSITIVE FACTORS
Focus on increasing awareness about epilepsy.
Commitment to improving lives through advocacy and research.
Efforts to mobilize community action for epilepsy.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+622%
120-day peak, hindsight
Typical move
2.4%
average across 3 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Full Press Release Details
The Epilepsy Foundation exists to end epilepsy. That means increasing awareness and changing the conversation around epilepsy, improving and saving lives through care, advocacy, research and new therapies, and education, and mobilizing everyone to take action.
Visit Site »
Frequently Asked Questions
What is the mission of the Epilepsy Foundation?
The mission is to end epilepsy through awareness, advocacy, and research.
How does the Epilepsy Foundation improve lives?
They improve lives by providing care, education, and mobilizing community action.
What initiatives does the Epilepsy Foundation support?
The foundation supports advocacy, research, new therapies, and education.
Biotech snapshot
Cash runway
$166M liquidity · $5M/mo burn
~33 mo
Minimal dilution risk
Catalyst track record
+622%
best trade around OVID's most recent catalyst
Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for OVID.